These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 5301644)
1. Treatment of active toxoplasmic retino-choroiditis. Nolan J; Rosen ES Br J Ophthalmol; 1968 May; 52(5):396-9. PubMed ID: 5301644 [No Abstract] [Full Text] [Related]
2. The treatment of toxoplasmic posterior uveitis (chorioretinitis). Giles CL Am J Med Sci; 1966 Feb; 251(2):241-2. PubMed ID: 5295371 [No Abstract] [Full Text] [Related]
3. [Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis]. Psilas K; Petroutsos G; Aspiotis M J Fr Ophtalmol; 1990; 13(11-12):551-3. PubMed ID: 2081846 [TBL] [Abstract][Full Text] [Related]
4. [Effect of treatment on the Sabin-Feldman test in ocular toxoplasmosis]. Ziobrowski S Klin Oczna; 1985 Aug; 87(8):324-6. PubMed ID: 3831574 [No Abstract] [Full Text] [Related]
7. [Ocular toxoplasmosis]. Fontaine M Cah Coll Med Hop Paris; 1967 Jan; 8(1):17-24. PubMed ID: 6036870 [No Abstract] [Full Text] [Related]
8. Manifestations and management of ocular toxoplasmosis. O'Connor GR Bull N Y Acad Med; 1974 Feb; 50(2):192-210. PubMed ID: 4521729 [No Abstract] [Full Text] [Related]
10. [Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment]. Timsit JC; Bloch-Michel E J Fr Ophtalmol; 1987; 10(1):15-23. PubMed ID: 3598056 [TBL] [Abstract][Full Text] [Related]
11. A case of toxoplasmic uveitis treated with pyrimethamine and sulpha drugs in Egypt (case report). Rifaat MA; Sadek MS; el-Naggar BA; Munir AM J Egypt Public Health Assoc; 1973; 48(5):364-8. PubMed ID: 4795184 [No Abstract] [Full Text] [Related]
13. [Ocular toxoplasmosis. Apropos of 29 cases illustrating the various clinical and serological forms]. Fontaine M; Desmonts G; Rousselie F Arch Ophtalmol Rev Gen Ophtalmol; 1965; 25(7):585-619. PubMed ID: 4221531 [No Abstract] [Full Text] [Related]
14. [Thirteen cases of active toxoplasmic retinochoroiditis]. Oniki S Nihon Ganka Kiyo; 1965 Nov; 16(11):793-807. PubMed ID: 5894435 [No Abstract] [Full Text] [Related]
15. How should active toxoplasmic retinochoroiditis be treated? Hay J; Dutton GN Eye (Lond); 1997; 11 ( Pt 6)():767-70. PubMed ID: 9537128 [No Abstract] [Full Text] [Related]
17. Ocular toxoplasmosis treatment and clinical monitoring of the patient. Terry JE; Young DD J Am Optom Assoc; 1982 Jul; 53(7):535-40. PubMed ID: 6896884 [TBL] [Abstract][Full Text] [Related]
18. White-centered retinal hemorrhages in ocular toxoplasmosis. Hayashi S; Kim MK; Belfort R Retina; 1997; 17(4):351-2. PubMed ID: 9279954 [No Abstract] [Full Text] [Related]
19. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin]. Colin J; Harie JC J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556 [TBL] [Abstract][Full Text] [Related]
20. Atypical spherical deposition on vitreoretinal interface associated with toxoplasmic chorioretinitis. Guagnini AP; De Potter P; Levecq L; Kozyreff A Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):158-60. PubMed ID: 16612633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]